⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DNLI News
Denali Therapeutics Inc. Common Stock
Form 8-K
sec.gov
DNLI
BIIB
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
globenewswire.com
BIIB
DNLI
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
globenewswire.com
BIIB
DNLI
Form 8-K
sec.gov
DNLI
Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights
globenewswire.com
DNLI
Orsini Selected as the Exclusive Specialty Pharmacy and Home Infusion Partner for Denali Therapeutics' AVLAYAH™ (tividenofusp alfa-eknm)
prnewswire.com
DNLI
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
globenewswire.com
SRPT
ALNY
DNLI
ARCT
Courier Health Releases 2026 State of Patient-Centricity in Biopharma Report
prnewswire.com
AZN
DNLI
GNE
PFE
UCB
Form 8-K
sec.gov
DNLI
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
globenewswire.com
DNLI